tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CARM Stock Latest News

Carisma Therapeutics, Inc. (CARM) Q4 Earnings Cheat Sheet
Pre-EarningsCarisma Therapeutics, Inc. (CARM) Q4 Earnings Cheat Sheet
1M ago
CARM
Carisma Therapeutics price target lowered to $1 from $12 at D. Boral Capital
PremiumThe Fly
Carisma Therapeutics price target lowered to $1 from $12 at D. Boral Capital
1M ago
CARM
Carisma Therapeutics Appoints Interim VP of Finance
PremiumCompany Announcements
Carisma Therapeutics Appoints Interim VP of Finance
5M ago
8K
CARM
Carisma Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Carisma Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
5M ago
CARM
Carisma investors should ‘stay the course,’ says D. Boral Capital
PremiumThe Fly
Carisma investors should ‘stay the course,’ says D. Boral Capital
5M ago
CARM
Carisma Therapeutics downgraded to Neutral from Outperform at Baird
PremiumThe FlyCarisma Therapeutics downgraded to Neutral from Outperform at Baird
5M ago
CARM
Carisma Therapeutics downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Carisma Therapeutics downgraded to In Line from Outperform at Evercore ISI
5M ago
CARM
MRNA
Carisma Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Carisma Therapeutics downgraded to Neutral from Buy at BTIG
5M ago
CARM
Carisma Therapeutics price target lowered to $12 from $24 at D. Boral Capital
PremiumThe Fly
Carisma Therapeutics price target lowered to $12 from $24 at D. Boral Capital
5M ago
CARM
Carisma Therapeutics announces restructuring, 34% workforce reduction
PremiumThe Fly
Carisma Therapeutics announces restructuring, 34% workforce reduction
5M ago
CARM
Carisma Therapeutics Restructures Amid Strategic Refocus
PremiumCompany Announcements
Carisma Therapeutics Restructures Amid Strategic Refocus
5M ago
8K
CARM
Carisma Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
PremiumThe Fly
Carisma Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
6M ago
CARM
Carisma Therapeutics reports data from its CAR-M therapy
PremiumThe FlyCarisma Therapeutics reports data from its CAR-M therapy
6M ago
CARM
MRNA
Carisma Therapeutics reports Q3 EPS (31c), consensus (26c)
Premium
The Fly
Carisma Therapeutics reports Q3 EPS (31c), consensus (26c)
6M ago
CARM
Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
Premium
The Fly
Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
6M ago
CARM
MRNA
Carisma Therapeutics, Inc. (CARM) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Carisma Therapeutics, Inc. (CARM) Q3 Earnings Cheat Sheet
6M ago
CARM
Leadership Transition at Carisma Therapeutics’ Board of Directors
PremiumCompany Announcements
Leadership Transition at Carisma Therapeutics’ Board of Directors
6M ago
8K
CARM
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
6M ago
BA
CWH
Carisma Therapeutics initiated with a Buy at EF Hutton
PremiumThe Fly
Carisma Therapeutics initiated with a Buy at EF Hutton
6M ago
CARM
Carisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
PremiumThe FlyCarisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
8M ago
CARM
MRNA
Carisma Therapeutics reports Q2 EPS (27c), consensus (30c)
Premium
The Fly
Carisma Therapeutics reports Q2 EPS (27c), consensus (30c)
9M ago
CARM
Carisma Therapeutics Board Changes and New Compensation Plans
Premium
Company Announcements
Carisma Therapeutics Board Changes and New Compensation Plans
10M ago
8K
CARM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >